The symptoms of chronic intraperitoneally GnIH-treated piglets exhibited hyperglycemia, a glucose intolerance, hypoinsulinism and hyperglucagon, which prompted us to decipher the molecular mechanism underlying the GnIH-mediated insulin resistance in insulin-stimulated glucose disposal tissues. The gene discussed is INS; the disease is Hyperglycemia.